Wandering Ozurdex® implant
Authors:
Open Access
- 30 September 2011
- journal article
- research article
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 2 (1) , 1-5
Abstract
Purpose To report the behavior of intravitreal Ozurdex® implant in eyes with post-lensectomy–vitrectomy (PLV) aphakia. Methods Retrospective chart review of three eyes with PLV aphakia (three patients with uveitis) who received intravitreal injection of Ozurdex® for cystoid macular edema (one eye), persistent inflammation (one eye), and ocular hypotony (one eye). Final outcome was assessed in terms of effectiveness, stability, and tolerance of the implant. Results Following the implant, an initial improvement was seen in all the three eyes. However, the implant migrated into the anterior chamber (AC) at 1 week in two eyes and at 5 weeks in one eye, and wandered between the AC and vitreous cavity with changing postures of the patient. Two eyes developed corneal edema, of which one eye underwent implant removal from the AC. Conclusion Ozurdex® implant should be contraindicated in eyes with PLV aphakia to avoid its deleterious effect on the corneal endothelium.Keywords
This publication has 9 references indexed in Scilit:
- DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTSRetina, 2011
- Treatment of Experimental Anterior and Intermediate Uveitis by a Dexamethasone Intravitreal ImplantInvestigative Ophthalmology & Visual Science, 2011
- Dexamethasone for ocular inflammationExpert Opinion on Pharmacotherapy, 2011
- The dexamethasone drug delivery system: Indications and evidenceAdvances in Therapy, 2011
- Clinical applications of the sustained-release dexamethasone implant for treatment of macular edemaClinical Ophthalmology, 2011
- Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implantClinical Ophthalmology, 2010
- Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein OcclusionOphthalmology, 2010
- Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass SyndromeAmerican Journal of Ophthalmology, 2009
- Randomized Controlled Study of an Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular EdemaArchives of Ophthalmology (1950), 2007